Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma

Metabolomics analysis possibly identifies new therapeutic targets in treatment resistance by measuring changes in metabolites accompanying cancer progression. We previously conducted a global metabolomics (G-Met) study of renal cell carcinoma (RCC) and identified metabolites that may be involved in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Tomonori, Kawasaki, Yoshihide, Maekawa, Masamitsu, Takasaki, Shinya, Morozumi, Kento, Sato, Masahiko, Shimada, Shuichi, Kawamorita, Naoki, Yamashita, Shinichi, Mitsuzuka, Koji, Mano, Nariyasu, Ito, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821950/
https://www.ncbi.nlm.nih.gov/pubmed/33374949
http://dx.doi.org/10.3390/metabo11010001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821950/
https://www.ncbi.nlm.nih.gov/pubmed/33374949
http://dx.doi.org/10.3390/metabo11010001

Ejemplares similares